Sue Bell was one of the first patients to receive the Alzheimer's drug lecanemab in 2020 as part of the clinical trial. It didn't stop the disease.

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

A new study found that some medications could have the unintended benefit of reducing dementia risk, while others could increase the risk. A doctor comments on the findings.

In “Doctored,” Charles Piller uncovers evidence that many important Alzheimer’s studies are based on faulty data.

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...

Jaime Bortz, 39, is losing her memory to dementia. Her mom, now a full-time carer, is foreshadowing the burden many families ...

The Western New York Chapter of the Alzheimer’s Association will hold an educational program in Salamanca on the common warning signs of Alzheimer’s disease or dementia and the ...

The Western New York Chapter of the Alzheimer’s Association will offer two free programs in the area next week — one on ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.